CU-CPT9a
Identifiers
  • 4-(7-methoxyquinolin-4-yl)-2-methylphenol
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC17H15NO2
Molar mass265.312 g·mol−1
3D model (JSmol)
  • CC1=C(C=CC(=C1)C2=C3C=CC(=CC3=NC=C2)OC)O
  • InChI=1S/C17H15NO2/c1-11-9-12(3-6-17(11)19)14-7-8-18-16-10-13(20-2)4-5-15(14)16/h3-10,19H,1-2H3
  • Key:HNYBTVKYLVLWCB-UHFFFAOYSA-N

CU-CPT9a is a drug which acts as a potent and selective antagonist of Toll-like receptor 8 (TLR8), with an IC50 of 0.5nM. Activation of toll-like receptors triggers release of cytokines and other signalling factors, leading to inflammation. This is an essential part of the immune system's response to infection, but chronic activation of TLR signalling is thought to be involved in various inflammatory and autoimmune disorders. CU-CPT9a has immunosuppressant properties, and may have applications in the treatment of autoimmune disorders, as well as being used in scientific research into the function of TLR8.[1][2][3][4][5]

See also

References

  1. ↑ Zhang S, Hu Z, Tanji H, Jiang S, Das N, Li J, et al. (January 2018). "Small-molecule inhibition of TLR8 through stabilization of its resting state". Nature Chemical Biology. 14 (1): 58–64. doi:10.1038/nchembio.2518. PMC 5726935. PMID 29155428.
  2. ↑ Hu Z, Tanji H, Jiang S, Zhang S, Koo K, Chan J, et al. (October 2018). "Small-Molecule TLR8 Antagonists via Structure-Based Rational Design". Cell Chemical Biology. 25 (10): 1286–1291.e3. doi:10.1016/j.chembiol.2018.07.004. PMC 6195466. PMID 30100350.
  3. ↑ Yang J, Lan J, Du H, Zhang X, Li A, Zhang X, et al. (March 2019). "Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells". European Journal of Pharmacology. 846: 12–22. doi:10.1016/j.ejphar.2018.12.026. PMID 30579933. S2CID 58567568.
  4. ↑ Venegas FA, Köllisch G, Mark K, Diederich WE, Kaufmann A, Bauer S, et al. (September 2019). "The Bacterial Product Violacein Exerts an Immunostimulatory Effect Via TLR8". Scientific Reports. 9 (1): 13661. Bibcode:2019NatSR...913661V. doi:10.1038/s41598-019-50038-x. PMC 6754391. PMID 31541142.
  5. ↑ Ehrnström B, Kojen JF, Giambelluca M, Ryan L, Moen SH, Hu Z, et al. (April 2020). "TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram-positive bacteria". Journal of Leukocyte Biology. 107 (4): 673–683. doi:10.1002/JLB.3A0120-114R. PMID 32083344.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.